Parents / 3M / Wilson / Fact Sheet for Patients / CDC / M.D. Principal Deputy / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
certain in vitro diagnostic devices / zanamivir products / manufacturing practice requirements / biological product / integrated assistance and services / authorized zanamivir products / authorized oseltamivir phosphate products / above zanamivir products / certain personal respiratory protection devices / treatment of uncomplicated acute illness / local law / unapproved medical product / oseltamivir phosphate products / above oseltamivir phosphate products / certain zanamivir products / certain oseltamivir phosphate products / phosphate products / /
MedicalCondition
specified disease / such disease / Swine Influenza A / such a disease / illness / MS / influenza / H1N1 Influenza A / serious bronchospasm / asthma / disease / uncomplicated acute illness / chronic obstructive pulmonary disease / influenza A / H1N1 flu / influenza infections / diseases / Influenza viruses / involving Swine Influenza A / /
MedicalTreatment
vaccination / /
Organization
office of Refugee Resettlement / DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration / Massachusetts office of Refugees / NOTICES AGENCY / Centers for Disease Control and Prevention Advisory Committee on Immunization Practices / Availability AGENCY / Occupational Safety and Health Administration / Centers for Disease Control and Prevention / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / federal government / Department of Human Services / FDA / Colorado Department / Local Public Health Authority / Department of Health and Human Services / office of Counterterrorism and Emerging Threats / Legislative Authority / /
Person
Boris Lushniak / Randall W. Lutter / Joshua M. Sharfstein / Charles E. Johnson / Richard E. Besser / /
Position
Deputy Commissioner for Policy / Secretary / Acting Director / Governor / Acting Secretary / Commissioner / Secretary of Defense that / representative / Acting Commissioner / Director / /
[removed]Federal Register / Vol. 74, No[removed]Tuesday, August 4, [removed]Notices 1 The specific products covered are listed below, in Section II (scope of authorization). For purposes of this document, we will refer to the